Status:

UNKNOWN

Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women

Lead Sponsor:

World Health Organization

Conditions:

Syphilis Female

Eligibility:

FEMALE

18+ years

Phase:

PHASE1

PHASE2

Brief Summary

Hypotheses The antibiotic, Cefixime, for use in non-pregnant women with early syphilis will be efficacious and safe. Primary Objective The primary objective of the study is to demonstrate the efficac...

Detailed Description

Hypotheses The antibiotic, Cefixime, for use in non-pregnant women with early syphilis will be efficacious and safe. Primary Objective The primary objective of the study is to demonstrate the efficac...

Eligibility Criteria

Inclusion

  • Female, 18 years of age or older
  • Non-pregnant
  • Able to provide informed consent
  • Test positive for syphilis with a positive TPPA AND an RPR titer equal to or greater than 1:8
  • Non-cephalosporin allergic
  • Non-penicillin allergic
  • Agree to be called once a day by study staff to be reminded to take study drug
  • Able to swallow pills
  • Willing to attend follow-up visits at 3, 6, and 9 months after completion of the study treatment
  • Willing to take oral contraceptive or use condom to prevent pregnancy during the study period
  • HIV negative

Exclusion

  • 1\) Female under 18 years of age 2) HIV positive 3) Pregnancy test positive or clinical pregnancy 4) Prior history of syphilis or syphilis treatment within 6 months of study screening 5) Allergy to penicillin or cephalosporins (including allergy to cefixime) 6) In the judgment of the interviewer, has a medical condition or other factor that might affect their ability to follow the protocol 7) Previous enrollment in the study 8) Presenting a condition that would not allow reliable informed consent (alcohol abuse or substance misuse) 9) Lacking mental capacity to give informed consent to participation
  • \-

Key Trial Info

Start Date :

November 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2021

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT03752112

Start Date

November 22 2019

End Date

September 30 2021

Last Update

February 5 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fortaleza University

Fortaleza, Ceará, Brazil